TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections January 30, 1998
TCL Archive NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities October 30, 1998
